UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in RYTM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$47,089,903
-$11,677,195 QoQ
Shares Held
541,450
-1.4% QoQ
Ownership
0.790%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 49.75251639117185.ToString("F0")%
Shared 0.ToString("F0")%
None 50.24748360882815.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. RYTM ranks #18 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in RYTM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,089,903 | 541,450 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $58,767,098 | 549,020 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $44,180,294 | 437,472 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,383,746 | 227,627 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,662,668 | 125,782 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $12,234,090 | 218,544 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,807,288 | 225,373 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,707,851 | 236,431 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,968,441 | 206,980 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,650,846 | 209,938 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,731,774 | 337,264 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,397,514 | 206,035 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,675,661 | 206,035 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,228,774 | 42,197 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $733,455 | 29,937 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $227,514 | 54,823 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $339,043 | 29,431 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $293,719 | 29,431 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $329,305 | 25,215 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $493,708 | 25,215 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $223,249 | 10,496 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $865,914 | 29,126 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $692,659 | 31,964 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $425,103 | 19,063 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||